Interferon-alpha-2b gene therapy
Alternative Names: GeneDrug™ - interferon-alpha-2bLatest Information Update: 12 Oct 2006
At a glance
- Originator Schering-Plough
- Developer Immune Response Corporation; Schering-Plough
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B; Hepatitis C
Most Recent Events
- 12 Oct 2006 No development reported - Preclinical for Hepatitis B in USA (unspecified route)
- 12 Oct 2006 No development reported - Preclinical for Hepatitis C in USA (unspecified route)
- 25 Jun 2002 This product is still in active development